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Background Data from West Africa indicate that a small thymus at birth and
at 6 months of age is a strong and independent risk factor for
infection-related mortality up to 24 and 36 months of age, respect-
ively. We investigated the association between thymus size (thymic
index, TI) in infancy and subsequent infant and child survival in a
contemporary South Asian population.
Methods The study focused on the follow-up of a randomized trial of
prenatal nutritional interventions in rural Bangladesh
(ISRCTN16581394), with TI measured longitudinally in infancy
(at birth and weeks 8, 24 and 52 of age) and accurate recording
of mortality up to 5 years of age.
Results A total of 3267 infants were born into the Maternal and Infant
Nutrition Interventions, Matlab study; data on TI were available
for 1168 infants at birth, increasing to 2094 infants by 52 weeks
of age. TI in relation to body size was largest at birth, decreasing
through infancy. For infants with at least one measure of TI avail-
able, there were a total of 99 deaths up to the age of 5 years. No
association was observed between TI and subsequent mortality
when TI was measured at birth. However, an association with mor-
tality was observed with TI at 8 weeks of age [odds ratio (OR) for
change in mortality risk associated with 1 standard deviation change
in TI: all deaths: OR¼ 0.64, 95% confidence interval (CI) 0.41, 0.98;
P¼ 0.038; and infection-related deaths only: OR¼ 0.32, 95% CI 0.14,
0.74; P¼ 0.008]. For TI when measured at 24 and 52 weeks of age,
the numbers of infection-related deaths were too few (3 and 1,
respectively) for any meaningful association to be observed.
Conclusion These results confirm that thymus size in early infancy predicts
subsequent survival in a lower mortality setting than West Africa.
The absence of an effect at birth and its appearance at 8 weeks of
age suggests early postnatal influences such as breast milk trophic
factors.
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Introduction
The past two decades have seen a growing interest in
the influence of the early life environment on early
development and long-term health outcomes; the
‘Developmental Origins of Health and Disease’
(DOHaD) hypothesis. The majority of published data
within this field of research have focused on chronic
disease outcomes, with only limited data on the
developmental origins of immunity and infectious dis-
ease risk or in resource-poor settings where this would
be most relevant. Evidence to support the concept of
early immune programming comes from studies on
vaccine responses1,2 and on the impact of the early
life environment on thymus development3,4 and func-
tion.5,6. Given the central role of the human thymus in
immune development, understanding whether and
how it can be shaped in early foetal and postnatal
life, and the long-term impact of this, is important.
The human thymus is a primary lymphoid organ
where bone marrow-derived precursors undergo dif-
ferentiation and selection, ultimately leading to the
migration of positively selected thymocytes to the per-
iphery.7,8 The early life development of the thymic
micro-environment is therefore critical for the estab-
lishment of a normal peripheral T-lymphocyte
immune system. Thymus development commences
early during fetal life, with the most critical period
of growth thought to occur between 7 and 14 weeks
of gestation.9 Although there remains lack of consen-
sus over the pattern and timescale of ‘normal’ thymus
growth and involution in humans,10 data suggest a
substantial increase in growth over the first 6
months of postnatal life,3 followed by a temporary
decrease until late infancy,11 with continuous
growth thereafter until involution in adolescence.
Thymus development in infants can be assessed
sonographically using a validated method in which
the transverse diameter of the thymus and the sagittal
area of its largest lobe are multiplied to give a volume-
related thymic index (TI).12 Research from our group
and others using this technique has shown that the
development of the human thymus is critically sensi-
tive to environmental exposures during early develop-
ment.3,4,13 A limitation of these studies, however, is
the lack of long-term follow-up to assess any possible
consequence of these early life effects.
We have previously reported on the environmental
determinants of thymic development in a large cohort
of rural Bangladeshi infants.4 We summarize the key
findings here: TI was strongly positively correlated to
current infant size (weight or length) and significantly
larger in male infants although, following adjustment
for infant weight, these differences only remained sig-
nificant for the measurements taken at 24 and 52
weeks of age. A significant effect of season of meas-
urement was observed at all time points; the measure-
ments taken at birth showed a biomodal pattern, with
largest TIs observed when measured in June and
December and smallest in March and September. At
all other time points, TI peaked only once during the
hot and dry months of the year, falling in size during
the monsoon and winter months. TI was not asso-
ciated with the prenatal supplementation groups, but
offspring of women who had received counselling in
exclusive breastfeeding had smaller TIs at 8 weeks of
age; although, by 52 weeks of age, infants who had
breastfed for greater than the median duration of days
had a larger TI. Within this analysis we did not, how-
ever, look at the longer-term effects of thymic devel-
opment on infant outcomes.
Evidence exists from both animal studies and obser-
vational research in humans to suggest poor thymus
development may lie on the causal pathway between
intra-uterine growth retardation (IUGR) and early
mortality. Studies using rodent models show that
low birthweight, resulting from maternal protein re-
striction during pregnancy, followed by catch-up
growth in rodents, is associated with shortened life-
span, whereas protein restriction and slow growth
during lactation lead to an increased lifespan.14 It is
proposed that these effects are mediated through dif-
ferential thymus growth.15 Research from Guinea-
Bissau, West Africa, indicates that a small thymus
at birth and at 6 months of age is a strong and inde-
pendent risk factor for infection-related mortality up
to 24 and 36 months of age, respectively.16,17 Given
the central role of the thymus in the establishment of
T-cell mediated immunity and the evidence to suggest
a long-term effect of impaired early thymic develop-
ment on subsequent mortality, but the lack of any
further replication of this observation, we investigated
the association between thymic index in infancy on
subsequent infant and child mortality in a contempor-
ary cohort from rural Bangladesh.
Materials and Methods
Study population
The study was conducted in the rural Matlab region of
Bangladesh. This population is well characterized,
having participated in a health and demographic
surveillance system (HDSS) since 1963 as part of a
health-related research programme led by the
International Centre for Diarrhoeal Disease Research,
Bangladesh (icddr,b). In 2001, icddr,b initiated the
Maternal and Infant Nutrition Interventions, Matlab
(MINIMat) study (ISRCTN16581394), randomizing all
pregnant women in Matlab to receive a combination of
protein-energy and micronutrient supplements. Full
details of the MINIMat study are given elsewhere.18
In brief, on enrolment (around 9 weeks of gestation),
women were randomly allocated to a prenatal food
supplement [randomized to start early in the first tri-
mester of pregnancy (early start) or in the second tri-
mester (usual start), as per the existing national
programme] in combination with three separate daily
micronutrient supplements: [(i) the UNICEF/UNU/
WHO preparation of 15 different micronutrients
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including 30 mg iron and 400mg folic acid; (ii) 60 mg
iron and 400mg folic acid; or (iii) 30 mg iron and
400mg folic acid] from week 14 during pregnancy.
All supplements continued up to birth. Perinatally,
women were further randomized to receive exclusive
breastfeeding counselling or the standard health coun-
selling provided by local caregivers. The prenatal arm
of the study was completed in June 2004 with a total
of 3267 singleton infants born.
Method
Within the main MINIMat trial, we looked at the
impact of early life nutritional and environmental de-
terminants of infant thymic development. The main
findings from this study have been published else-
where.4 For this study on thymic development,
mothers and their infants were recruited from the
main MINIMat trial either at birth (for health
centre deliveries) or at follow-up (for all other births).
For health centre deliveries, birthweight, length,
head circumference and knee-heel lengths were mea-
sured immediately following delivery. For births
occurring at home, a birth notification system was
established to ensure that study staff were made
aware of births as soon as they occurred. A female
paramedic then visited the newborn within 72 h of
birth. Birthweight was measured by electronic or
beam scales, to the nearest 10 g. Recumbent length
was measured using locally manufactured, collapsible
length boards, precise to the nearest 1 mm.
Following delivery, infant weight and length were
measured at monthly visits to 12 months of age, and
then 3-monthly up to 2 years of age, then at 5 years of
age, using regularly validated standard equipment. At
separate monthly visits, a female fieldworker visited
each household to collect information on infant feed-
ing practices. Full details are described elsewhere.18
Data on feeding practices were later coded and breast-
feeding status classified on the basis of current WHO
recommendations19: (i) exclusive breastfeeding (breast
milk only); (ii) predominant breastfeeding (breast
milk plus other liquids such as water, tea or juice);
and (iii) partial breastfeeding (other food or milk in
addition to breast milk). Socio-economic status (SES)
was estimated using a wealth index based on infor-
mation on household assets and estimated by princi-
pal component analysis, producing a weighted score.20
Scores were grouped into quintiles.
Thymus ultrasound
Thymus size was measured by trained paramedics
using a portable ultrasound machine (Toshiba SSA
320A Justavision-200, Toshiba Medical Systems,
Japan) together with a PVF-745V 5.0-7.0 MHz probe
(Toshiba Medical Systems, UK). The TI was calculated
using the mean of three measurements of both the
transverse diameter and the sagittal plane.
A total of eight paramedics conducted the thymus
scans. These paramedics had previously been trained
to perform fetal biometry, to a high degree of accur-
acy.21 Prior to the start of the thymus scans, all sono-
graphers received extensive training on the technique
and underwent a series of standardization exercises to
document intra- and interobserver reliability for both
measurements (data not presented).
TI was assessed at four time points during infancy:
within 24 h of birth and at 8, 24 and 52 weeks of age.
Infants were scanned in the supine position, using
a trans-sternal approach; sonography was not per-
formed while the infant was crying, instead we
would wait until the infant was calm before perform-
ing the scan. Only infants who were delivered at a
health centre had a TI measurement made at birth.
In order to maximize the number of data points at
each subsequent visit, we then scanned all infants
attending the clinic visits, irrespective of what other
time points they had data from. Owing to a delay
with the start of TI assessment, a large proportion
of infants had passed 24 weeks by the time the
study started; this resulted in more infants with TI
measured at the final time point.
Mortality data collection
The impact of nutritional supplementation on infant
and childhood mortality is described in detail else-
where.18 Ascertaining and attributing causes of death
was done in accordance with the verbal autopsy stand-
ards that have been developed by the INDEPTH net-
work and the World Health Organization.22
Community health research workers detected and re-
corded death through monthly household visits.
Information was collected at home interviews with
caretakers/relatives who had lived with the deceased
in the same household at the time of death. Three
independent physicians read the available information
and assigned International Classification of Diseases,
version 10 (ICD-10) codes. In case of disagreement,
the cause was assigned after a consensus process.
Definitions of mortality were: early neonatal—death
within days 0–6 of birth; late neonatal—death between
days 7 to 27; post neonatal—death between days 28 to
364; and child—death between days 365 to 1824.
Further, an infant death was defined as all deaths of
a live birth before 364 days of age, and a child death as
death of a live birth before 5 years of age.
Statistical methods
The analysis was performed in two stages: (i) adjust-
ing TI measurements for season and infant size,
sex and age; and (ii) logistic regression using the ad-
justed TI measurement as a predictor of death. TI
measurements were adjusted by first regressing raw
TI measurements on infant length, weight, age, sex
and the first two Fourier terms for season of measure-
ment.4 As previously, two separate seasonal patterns
were calculated: one for birth data and the second for
all postnatal time points, the latter fitted using a
multilevel model. The standardized residuals were
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then calculated: the predicted value from the above
regression was subtracted from each TI measurement
and the result divided by the standard deviation for
the time point. The resultant adjusted TI measure-
ments were then entered as predictors in logistic re-
gression analysis. A separate logistic regression
predicting the risk of death between the age of meas-
urement and 5-years models were fitted for each time
point (birth, 2, 6 and 12 months of age). These logistic
regression models were repeated for deaths due to in-
fection by removing all data on children dying of other
causes. Effects of breastfeeding status were explored
by adding duration of exclusive breastfeeding to the
logistic regression model. We also extended these
models to include sex and its interaction with adjusted
TI. Data were analysed using DataDesk (Version 6.1,
Data Description, Ithaca, NY) and Stata Statistical
Software: Release 12 (Statacorp, College Station, TX).
Ethical considerations
The main MINIMat study and the thymus size adden-
dum were approved by the Research Review and
Ethical Review Committees, ICDDR,B, Dhaka, Bangla-
desh. The thymus size addendum was additionally
approved by the Ethics Committee at the London
School of Hygiene and Tropical Medicine. Written in-
formed consent was obtained from all participating
mothers following an explanation of the study in
their own language.
Results
A total of 3267 singleton infants were born into the
MINIMat study; full details of the main outcome
measures are given in detail elsewhere.18 A total of
1168 infants had TI measurements taken at birth
(health centre deliveries only), 1715 at 8 weeks,
1704 at 24 weeks and 2093 at 52 weeks of age; this
increase to the final data collection point being a con-
sequence of a delay starting ultrasound measurements
in the field. The corresponding figures for those with
anthropometry data available, and hence adjusted
TI measurements, were 1168 at birth, 1627 at 8
weeks, 1595 at 24 weeks and 2022 at 52 weeks of
age. Figure 1 details mean TI at birth (health centre
deliveries only) and at 8, 24 and 52 weeks of infant
age and TI expressed in relation to body weight. As
previously reported in detail,4 TI in relation to body
size was greatest at birth, decreasing to the measure-
ments taken at 52 weeks of age.
Within the MINIMat study, there was a total of
111 deaths before the cohort all reached 5 years of
age. Of these, 34 were early neonatal deaths (0–6
days), 13 late neonatal deaths (7–27 days), 27 post
neonatal deaths (28–364 days); and 37 child deaths
(365–1824 days). For the purpose of this analysis,
only subjects with data on TI have been included;
this reduced the total number of deaths to 49: 17 in
infancy (<365 days) and the remaining 32 in child-
hood (365–1824 days). Table 1 summarizes child sur-
vival status and cause of death among those with TI
observations at each time point. For example, of the
1168 infants with a TI measured at birth, 1140 were
alive at follow-up to 5 years of age, 14 died in infancy
and 14 died in childhood. Cause of death included 12
infections, 1 asphyxia, 1 malformation, 13 other and 1
death had an unknown cause.
Table 2A summarizes results of logistic regression of
TI at each time point (birth and 8, 24 and 52 weeks of
age) on infant and child survival. TI measurements
are adjusted for infant size, sex and season of meas-
urement and are presented for all deaths combined,
then separately for infection-related deaths only.
Analyses of the TI measurements taken at birth are
also presented with neonatal deaths excluded. Odds
ratios (OR) and 95% confidence intervals (95% CI) are
presented for the change in mortality risk with a 1
standard deviation change in TI. TI when measured at
birth was not associated with risk of death up to the
age of 5 years. For measurements made at 8 weeks of
age, a marginally significant association was observed
between TI and death (OR¼ 0.64, 95% CI 0.41, 0.98;
P¼ 0.038) which was strengthened when only infec-
tion-related deaths were included (OR¼ 0.27, 95% CI
0.14, 0.74; P¼ 0.008). For TI at 24 weeks of age, no
association was observed in the model with all deaths
included, although when infection-relation only
deaths were included, a significant association ap-
peared (OR¼ 0.27, 95% CI 0.08, 0.95, P¼ 0.041).
However, this analysis was based on only three
deaths, and so must be interpreted with caution.
Only a single death occurred up to 5 years of age in
subjects with a TI at measured at 52 weeks of age,
and hence an analysis would not be meaningful.
Controlling for breastfeeding made a negligible differ-
ence to the results (Table 2B). Finally, we tested for a
sex-TI interaction, but no significant results were ob-
tained (data not presented).
Discussion
Previous studies from Guinea Bissau report associ-
ations between thymus size when measured at
birth16 and at 6 months of age17 with subsequent
mortality up to 24 and 36 months of age, respectively;
infants with a smaller thymus had increased risk of
subsequent mortality from infection-related causes.
The current study, using identical techniques to meas-
ure thymus size as in Guinea Bissau, provides some
further evidence to support an association with child
survival to 5 years of age in a much larger cohort of
infants from rural Bangladesh, with serial ultrasound
measurement available from birth to 1 year of age. At
8 weeks of age, a significant trend was observed be-
tween TI and subsequent mortality from all causes
and for infection-related deaths only.
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Infectious diseases remain the major cause of mor-
bidity and mortality in infants and children under 5
years of age in living in sub-Saharan Africa. It is well
established that low birthweight and IUGR infants
have increased risk of morbidity and mortality
during infancy, although the mechanism(s) for
these effects are not known. Given the central role
of the thymus in the establishment of a normal per-
ipheral T-lymphocyte immune system, replication of
the findings from Guinea Bissau within other com-
parative cohorts is important.
The fetal T-cell (and B-cell) development begins at
the end of the first trimester, with a rapid expansion
of cell numbers through early childhood. This expan-
sion involves the de novo production and export by the
thymus of transitional T-cells (recent thymic emi-
grants; RTE), which then mature into naı¨ve cells in
the periphery. Insults during critical windows of de-
velopment may therefore programme the structure
and/or function of the thymus, permanently altering
specific cell populations and leading to subsequent
immune deficiencies. Such cellular changes would
likely include a diminished output of T-lymphocytes,
indicated by a reduction in the number of circulating
naı¨ve T-cells. Whereas studies of RTE dynamics in
humans have been complicated by the lack of defini-
tive markers of RTE status, markers such as T-cell re-
ceptor excision circles (TRECs) within cell populations
have typically been used to assess thymic output.23
More recently, the use of surrogate markers of RTE
status such as the surface molecules CD31 (platelet
endothelial cell adhesion molecule-1)24 and PTK7
(protein tyrosine kinase 7)25 are being implicated as
robust measures to assess thymus output. In a setting
of high infectious exposure, defects in T-cell immunity
would likely put an infant at a greater risk of disease,
supporting the biological plausibility of a link between
TI and subsequent mortality.
The data on thymus development collected within
the MINIMat trial represent the largest published
dataset of this nature to date, and the most detailed
with longitudinal measures between birth and 52
weeks of age. Consistent with the literature, TI in re-
lation to body size was largest at birth, decreasing
thereafter. There was also a strong influence of
season of measurement on TI, indicating plasticity
of the developing thymus to environmental exposures.
Strengths of the current study therefore include the
large sample size, the prospective and longitudinal
nature of the data collected and the detailed recording
of date and cause of death. Limitations of the study
include the lack of any further measures of thymic
output or function, and the reliance on a sonographic
estimation of thymic volume.
The main limitation of the current analysis, however,
is the relatively low number of deaths after 6 months
of age, precluding any meaningful analysis of the TI
data collected after this time. This observation is the
most likely explanation for a difference in findings
between the current study and those previously pub-
lished from Guinea Bissau. In the study from Guinea
Bissau, where infants were measured at birth and fol-
lowed to 24 months of age, the neonatal mortality rate
(MR) was 39/1000, infant MR 117/1000 and the
under-two MR 175/1000.16 In the second study from
the same population area, where infants were mea-
sured at 6 months of age and followed to 36 months
of age, there were 68 deaths from a population sample
of 923 children.17 In the current study from rural
Bangladesh, the early neonatal MR (deaths before 7
days of age) was 28/1000, the infant MR 42/1000 and
the childhood MR (to 5 years of age) 49/1000; these
Table 1 Number of infants with TI measurements available
at each time point, and the status and cause of death of
these infants, by time point
Number of infants
Birth 8 weeks 24 weeks
Total number of TI observations 1168 1627 1595
Status
Alive 1140 1601 1572
Death in infancy 14 7 2
Death in childhood 14 19 21
Cause of deatha
Infection 12 8 3
Asphyxia 1
Preterm, LBW
Malformation 1
Other 13 17 19
Unknown 1 1 1
LBW, low birthweight.
aCause-of-death groups are based on ICD10 codes.
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rates reflect far fewer deaths than observed in Guinea
Bissau, especially after the neonatal period. Moreover
there was a smaller proportion of infection-related
deaths in Bangladesh.
Of note, the absolute TIs from the current study
appeared larger than those published from the
Guinea Bissau studies16,17 and from other published
data from The Gambia3 and Denmark.11,13 Whereas
all studies used an identical technique for assessing
the size of the thymus, differences in the absolute
sizes measured could result from differences in equip-
ment used (note that the studies from The Gambia,
Guinea Bissau and Denmark all used the same ma-
chine with similar, although not identical, probes,
whereas the study from Bangladesh used a different
machine and probe), inter-observer differences across
sites, or potentially from genuine differences between
population groups. A cross-sectional study performed
on two South American native populations (the
Tsimane of Bolivia and the Pume´ of Venezuela)
showed that, despite nearly identical anthropometric
trajectories, Tsimane infants had larger thymuses
than Pume´ infants at all ages.26 The authors conclude
that these findings reveal a cross-cultural difference
in thymus size that is not driven by nutritional fac-
tors. Pume´ infants have smaller thymuses than
Tsimane, and the authors describe how Pume´
mothers are subjected to greater seasonal and envir-
onmental stressors, compared with the Tsimane; this
combination of adverse prenatal factors is likely to
negatively impact on fetal thymic development and
contribute to smaller thymus size in Pume´ newborns.
Translating these data back to the current study, the
smaller TI in infants from Guinea Bissau compared
with Bangladesh may reflect a ‘read-out’ of a poorer
environment and contribute to the differences
observed between TI and subsequent mortality.
However, the fact that TIs from healthy Danish in-
fants track almost exactly to those from Bissau
makes this explanation unlikely. A prospective study
of thymus development across population sites is thus
warranted, to help understand the patterns and
sources of variation in postnatal thymic development
in more detail. However, given that the current ana-
lysis is based on differences in TI within a population
group, it is unlikely that any differences in absolute
size of the thymus have contributed to the observed
lack of a consistent association between TI and infant
and child mortality.
We have previously observed, within this population
of Bangladeshi infants, that a smaller leg length rela-
tive to head circumference, assessed sonographically in
utero and characteristic of head-sparing growth restric-
tion, was predictive of a lower TI postnatally,27 indicat-
ing that growth patterns typical of poor fetal nutrition
are associated with poor thymic development. Added
to the data from the current analysis and those from
Guinea Bissau, these findings infer that appropriate
nutrition early in pregnancy is important for the de-
veloping thymus and for prevention of infection-
related mortality through infancy and beyond.
Infant feeding status has been shown as an import-
ant determinant of thymus size in early infancy, with
breastfed Danish infants observed to have larger TIs
compared with those who were bottle fed,13 potentially
due to the interleukin-7 (IL-7) content in breast milk
promoting thymic growth.6 However, within the cur-
rent study, breastfeeding status, as assessed by mean
Table 2 (A) Logistic regression of thymic index on survival for all deaths, and infection-related deaths only. Table 2B
Association controlling for duration exclusively breastfed
Time point
Deaths
(number)
A B
OR per SDa 95% CI for OR P-value OR per SDa 95% CI for OR p-value
All deaths
Birth 28 0.93 0.63, 1.36 0.69 0.92 0.62, 1.35 0.67
Birth (NN deaths excluded) 24 0.95 0.63, 1.44 0.82 0.95 0.63, 1.43 0.8
8 weeks 26 0.64 0.41, 0.98 0.038 0.63 0.41, 0.97 0.035
24 weeks 23 0.93 0.61, 1.40 0.73 0.92 0.61, 1.39 0.69
52 weeks 22 1.02 0.67, 1.55 0.94 1.01 0.66, 1.54 0.98
Infection-related deaths onlyb
Birth 12 0.62 0.32, 1.19 0.15 0.61 0.32, 1.18 0.14
Birth (NN deaths excluded) 9 0.62 0.29, 1.30 0.20 0.62 0.29, 1.30 0.20
8 8 0.32 0.14, 0.74 0.008 0.31 0.13, 0.73 0.007
24 3 0.27 0.08, 0.95 0.041 0.29 0.08, 1.03 0.056
OR, odds ratio; SD, standard deviation; CI, confidence interval; NN, neonatal. Values in bold represent significant associations
between thymic index and death, at the <0.05 level.
aOR for change in mortality risk associated with 1 SD change in thymic index.
bFor infection-related deaths after 52 weeks of age, only one death was observed and hence analysis was not performed. Within the
adjusted analysis, in no case was the breastfeeding term significant.
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duration of exclusive breastfeeding, did not alter the
associations between TI and mortality as reported.
Whereas it is possible that the method selected to
adjust for breast-feeding status within the model was
not sensitive enough, this finding does not support the
premise that the observed association between TI and
subsequent mortality was a reflection of differential
infant feeding practices driving thymic development.
In summary, the current study provides support for
the previously observed associations between thymus
size in infancy and subsequent childhood mortality.
The lack of a strong and consistent association
across time points is most likely a consequence of
the lower rates of mortality observed in rural
Bangladesh. Our previous demonstration of a likely
link between early life nutrition and TI,27 and the
evidence provided here and elsewhere of an impact
on mortality from infectious diseases, also have im-
plications for populations with low rates of infection.
Future work in this field should focus on understand-
ing the aetiology of discordant thymic development
(small thymus in relation to body size), and the
longer-term immunological consequences of this.
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KEY MESSAGES
 Early development of the human thymus is sensitive to nutritional and environmental exposures.
 Previous data from infants born in an area with a high incidence of infections and a high rate of
infant mortality have shown a relationship between a small thymus at birth and at 6 months of age
and higher infant and childhood mortality.
 Here we repeat this analysis in a cohort of rural Bangladeshi infants, and provide evidence to confirm
that thymus size in early infancy predicts subsequent survival, even in a lower mortality setting.
 The size of effect at 8 weeks of age, when most infants are predominantly breastfed, implicates a role
of breast milk trophic factors, although the current data are not able to support this.
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